J. Kazmierski

Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic Investigators.

F. Van de Werf, K. Coyne, J. Reiner, 1996, Circulation.

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

R. D. Jenkins, Andreas Wilke, A. Capucci, 2022, Clinical Research in Cardiology.

Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry.

R. D. Jenkins, A. Capucci, G. Lip, 2020, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

The Angiographic Fate of Infarct Related Arteries with TIMI 2 Flow Following Thrombolysis for Acute Myocardial Infarction

J. Reiner, C. Lundergan, A. Ross, 1995 .

Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation

D. Singer, G. Fonarow, L. Allen, 2020, Circulation. Arrhythmia and electrophysiology.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

James S. Crenshaw, R. D. Jenkins, David W. Smith, 2023, EClinicalMedicine.

Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction

Daniel C. Lee, N. Cook, D. Delurgio, 2018, JAMA cardiology.